4,099 reports of this reaction
1.4% of all CYCLOPHOSPHAMIDE INJECTION, SOLUTION reports
#17 most reported adverse reaction
PANCYTOPENIA is the #17 most commonly reported adverse reaction for CYCLOPHOSPHAMIDE INJECTION, SOLUTION, manufactured by Alembic Pharmaceuticals Inc.. There are 4,099 FDA adverse event reports linking CYCLOPHOSPHAMIDE INJECTION, SOLUTION to PANCYTOPENIA. This represents approximately 1.4% of all 284,200 adverse event reports for this drug.
Patients taking CYCLOPHOSPHAMIDE INJECTION, SOLUTION who experience pancytopenia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
PANCYTOPENIA is a less commonly reported adverse event for CYCLOPHOSPHAMIDE INJECTION, SOLUTION, but still significant enough to appear in the safety profile.
In addition to pancytopenia, the following adverse reactions have been reported for CYCLOPHOSPHAMIDE INJECTION, SOLUTION:
The following drugs have also been linked to pancytopenia in FDA adverse event reports:
PANCYTOPENIA has been reported as an adverse event in 4,099 FDA reports for CYCLOPHOSPHAMIDE INJECTION, SOLUTION. This does not prove causation, but indicates an association observed in post-market surveillance data.
PANCYTOPENIA accounts for approximately 1.4% of all adverse event reports for CYCLOPHOSPHAMIDE INJECTION, SOLUTION, making it a notable side effect.
If you experience pancytopenia while taking CYCLOPHOSPHAMIDE INJECTION, SOLUTION, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.